Enhance your nephrology practice with CME and tools focused on kidney medicine.
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP
Leonie Kraft, MD
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Elevating CKD-aP Care: New Frontier
Kappa-Opioid Settings: Real-World Evidence Insights
The Patient-Clinician Connection in Managing CKD-aP
CKD-aP or Something Else? Decoding the Diagnosis
Precision Medicine in IgAN: A Deep Dive into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
Chee Kay Cheung, MBCHB, MRCP, PHD
Raphael Duivenvoorden, MD, PhD
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Javed Butler, MD, MPH, MBA
CKD-aP Treatment Tool Kit
Is CKD-aP Hiding in Your Dialysis Center?
Improving Sleep and Mental Health in Patients with CKD-aP
Future Directions in Managing Hyperkalemia in CKD and HF
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Patrick Rossignol, MD, PhD
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
The Critical Interplay: CKD, HF, and HyperkaleAmia
Potassium Binders in Practice: Clinical Trial Evidence
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.